Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma

Science Translational Medicine

Volumn 5, Issue 212, 2013, Pages

  Drabovich, Andrei P ^a   Dimitromanolakis, Apostolos ^b   Saraon, Punit ^c   Soosaipillai, Antoninus ^b   Batruch, Ihor ^b   Mullen, Brendan ^b   Jarvi, Keith ^a,b,c   Diamandis, Eleftherios P ^a,b,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ECM1; PROTEIN TEX101; SEMINAL PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; AZOOSPERMIA; BIOLOGICAL MONITORING; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOENRICHMENT MASS SPECTROMETRY BASED ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; REFERENCE VALUE; RELIABILITY; REPRODUCIBILITY; SEMEN ANALYSIS; SEMINAL PLASMA; SENSITIVITY AND SPECIFICITY; SERTOLI CELL ONLY SYNDROME; SPERMATOGENESIS; TESTIS BIOPSY;

AZOOSPERMIA; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MALE; MEMBRANE PROTEINS; PROTEOME; SEMEN;

EID: 84890334931     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006260     Document Type: Article

References (39)

1. Male Infertility Best Practice Policy Committee of the American Urological Association; Practice Committee of the American Society for Reproductive Medicine, Report on evaluation of the azoospermic male. Fertil. Steril. 86, S210-S215 (2006).
2. W. D. Mosher, Reproductive impairments in the United States, 1965-1982. Demography 22, 415-430 (1985).
3. J. de Mouzon, V. Goossens, S. Bhattacharya, J. A. Castilla, A. P. Ferraretti, V. Korsak, M. Kupka, K. G. Nygren, A. N. Andersen; European IVF-Monitoring (EIM); Consortium for the European Society on Human Reproduction and Embryology (ESHRE), Assisted reproductive technology in Europe, 2007: Results generated from European registers by ESHRE. Hum. Reprod. 27, 954-966 (2012).
4. J. P. Jarow, M. A. Espeland, L. I. Lipshultz, Evaluation of the azoospermic patient. J. Urol. 142, 62-65 (1989).
5. R. I. McLachlan, E. Rajpert-De Meyts, C. E. Hoei-Hansen, D. M. de Kretser, N. E. Skakkebaek, Histological evaluation of the human testis - Approaches to optimizing the clinical value of the assessment: Mini review. Hum. Reprod. 22, 2-16 (2007).
6. Practice Committee of the American Society for Reproductive Medicine, Report on management of obstructive azoospermia. Fertil. Steril. 86, S259-S263 (2006).
7. G. R. Dohle, S. Elzanaty, N. J. van Casteren, Testicular biopsy: Clinical practice and interpretation. Asian J. Androl. 14, 88-93 (2012).
8. A. Carpi, E. Sabanegh, J. Mechanick, Controversies in the management of nonobstructive azoospermia. Fertil. Steril. 91, 963-970 (2009).
9. S. Muttukrishna, H. Yussoff, M. Naidu, J. Barua, K. Arambage, H. Suharjono, M. Sathanandan, Serum anti-Müllerian hormone and inhibin B in disorders of spermatogenesis. Fertil. Steril. 88, 516-518 (2007).
10. C. Tsametis, G. Mintziori, P. K. Iliadou, B. C. Tarlatzis, I. Papadimas, D. G. Goulis, Dynamic endocrine test of inhibin B and anti-Müllerian hormone in men with non-obstructive azoospermia. Gynecol. Endocrinol. 27, 661-665 (2011).
11. E. P. Diamandis, W. P. Arnett, G. Foussias, H. Pappas, S. Ghandi, D. N. Melegos, B. Mullen, H. Yu, J. Srigley, K. Jarvi, Seminal plasma biochemical markers and their association with semen analysis findings. Urology 53, 596-603 (1999).
12. A. P. Drabovich, K. Jarvi, E. P. Diamandis, Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol. Cell. Proteomics 10, M110.004127 (2011).
13. I. Batruch, I. Lecker, D. Kagedan, C. R. Smith, B. J. Mullen, E. Grober, K. C. Lo, E. P. Diamandis, K. A. Jarvi, Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system. J. Proteome Res. 10, 941-953 (2010).
14. I. Batruch, C. R. Smith, B. J. Mullen, E. Grober, K. C. Lo, E. P. Diamandis, K. A. Jarvi, Analysis of seminal plasma from patients with non-obstructive azoospermia and identification of candidate biomarkers of male infertility. J. Proteome Res. 11, 1503-1511 (2012).
15. A. P. Drabovich, M. P. Pavlou, A. Dimitromanolakis, E. P. Diamandis, Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay. Mol. Cell. Proteomics 11, 422-434 (2012).
16. J. R. Whiteaker, C. Lin, J. Kennedy, L. Hou, M. Trute, I. Sokal, P. Yan, R. M. Schoenherr, L. Zhao, U. J. Voytovich, K. S. Kelly-Spratt, A. Krasnoselsky, P. R. Gafken, J. M. Hogan, L. A. Jones, P. Wang, L. Amon, L. A. Chodosh, P. S. Nelson, M. W. McIntosh, C. J. Kemp, A. G. Paulovich, A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29, 625-634 (2011).
17. T. A. Addona, X. Shi, H. Keshishian, D. R. Mani, M. Burgess, M. A. Gillette, K. R. Clauser, D. Shen, G. D. Lewis, L. A. Farrell, M. A. Fifer, M. S. Sabatine, R. E. Gerszten, S. A. Carr, A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol. 29, 635-643 (2011).
18. R. Hüttenhain, M. Soste, N. Selevsek, H. Röst, A. Sethi, C. Carapito, T. Farrah, E. W. Deutsch, U. Kusebauch, R. L. Moritz, E. Niméus-Malmström, O. Rinner, R. Aebersold, Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4, 142ra94 (2012).
19. T. Takayama, T. Mishima, M. Mori, T. Ishikawa, T. Takizawa, T. Goto, M. Suzuki, Y. Araki, S. Matsubara, T. Takizawa, TEX101 is shed from the surface of sperm located in the caput epididymidis of the mouse. Zygote 13, 325-333 (2005).
20. Y. Fujihara, K. Tokuhiro, Y. Muro, G. Kondoh, Y. Araki, M. Ikawa, M. Okabe, Expression of TEX101, regulated by ACE, is essential for the production of fertile mouse spermatozoa. Proc. Natl. Acad. Sci. U.S.A. 110, 8111-8116 (2013).
21. L. Yin, C. M. Chung, R. Huo, H. Liu, C. Zhou, W. Xu, H. Zhu, J. Zhang, Q. Shi, H. Y. Wong, J. Chen, Y. Lu, Y. Bi, C. Zhao, Y. Du, M. Ma, Y. Cai, W. Y. Chen, K. L. Fok, L. L. Tsang, K. Li, Y. Ni, Y. W. Chung, Z. Zhou, J. Sha, H. C. Chan, A sperm GPI-anchored protein elicits sperm-cumulus cross-talk leading to the acrosome reaction. Cell. Mol. Life Sci. 66, 900-908 (2009).
22. T. T. Sun, C. M. Chung, H. C. Chan, Acrosome reaction in the cumulus oophorus revisited: Involvement of a novel sperm-released factor NYD-SP8. Protein Cell 2, 92-98 (2011).
23. L. M. Su, G. D. Palermo, M. Goldstein, L. L. Veeck, Z. Rosenwaks, P. N. Schlegel, Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: Testicular histology can predict success of sperm retrieval. J. Urol. 161, 112-116 (1999).
24. T. Ishikawa, Surgical recovery of sperm in non-obstructive azoospermia. Asian J. Androl. 14, 109-115 (2012).
25. S. M. Heshmat, J. B. Mullen, K. A. Jarvi, A. Soosaipillai, E. P. Diamandis, R. J. Hamilton, K. C. Lo, Seminal plasma lipocalin-type prostaglandin D synthase: A potential new marker for the diagnosis of obstructive azoospermia. J. Urol. 179, 1077-1080 (2008).
26. A. D. Rolland, R. Lavigne, C. Dauly, P. Calvel, C. Kervarrec, T. Freour, B. Evrard, N. Rioux-Leclercq, J. Auger, C. Pineau, Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum. Reprod. 28, 199-209 (2013).
27. B. Pilch, M. Mann, Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol. 7, R40 (2006).
28. D. Kagedan, I. Lecker, I. Batruch, C. Smith, I. Kaploun, K. Lo, E. Grober, E. P. Diamandis, K. A. Jarvi, Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry. Clin. Proteomics 9, 2 (2012).
29. X. Liu, X. Yu, D. J. Zack, H. Zhu, J. Qian, TiGER: A database for tissue-specific gene expression and regulation. BMC Bioinformatics 9, 271 (2008).
30. E. Mathieu, L. Meheus, J. Raymackers, J. Merregaert, Characterization of the osteogenic stromal cell line MN7: Identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J. Bone Miner. Res. 9, 903-913 (1994).
31. S. Sercu, A. M. Lambeir, E. Steenackers, A. El Ghalbzouri, K. Geentjens, T. Sasaki, N. Oyama, J. Merregaert, ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain. Matrix Biol. 28, 160-169 (2009).
32. H. Jin, H. Yoshitake, H. Tsukamoto, M. Takahashi, M. Mori, T. Takizawa, K. Takamori, H. Ogawa, K. Kinoshita, Y. Araki, Molecular characterization of a germ-cell-specific antigen, TEX101, from mouse testis. Zygote 14, 201-208 (2006).
33. A. Kurita, T. Takizawa, T. Takayama, K. Totsukawa, S. Matsubara, H. Shibahara, M. C. Orgebin-Crist, F. Sendo, Y. Shinkai, Y. Araki, Identification, cloning, and initial characterization of a novel mouse testicular germ cell-specific antigen. Biol. Reprod. 64, 935-945 (2001).
34. S. B. Sleight, P. V. Miranda, N. W. Plaskett, B. Maier, J. Lysiak, H. Scrable, J. C. Herr, P. E. Visconti, Isolation and proteomic analysis of mouse sperm detergent-resistant membrane fractions: Evidence for dissociation of lipid rafts during capacitation. Biol. Reprod. 73, 721-729 (2005).
35. P. V. Miranda, A. Allaire, J. Sosnik, P. E. Visconti, Localization of low-density detergent-resistant membrane proteins in intact and acrosome-reacted mouse sperm. Biol. Reprod. 80, 897-904 (2009).
36. L. L. Yin, C. M. Chung, J. Chen, K. L. Fok, C. P. Ng, R. R. Jia, X. Ren, J. Zhou, T. Zhang, X. H. Zhao, M. Lin, H. Zhu, X. H. Zhang, L. L. Tsang, Y. Bi, Z. Zhou, F. Mo, N. Wong, Y. W. Chung, J. Sha, H. C. Chan, A suppressor of multiple extracellular matrix-degrading proteases and cancer metastasis. J. Cell. Mol. Med. 13, 4034-4041 (2009).
37. X. Teng, J. Yang, Y. Xie, Z. Ni, R. Hu, L. Shi, Z. Lin, L. Hu, G. Zhao, X. Ding, X. Kong, A novel spermatogenesis-specific uPAR gene expressed in human and mouse testis. Biochem. Biophys. Res. Commun. 342, 1223-1227 (2006).
38. N. Schultz, F. K. Hamra, D. L. Garbers, A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc. Natl. Acad. Sci. U.S.A. 100, 12201-12206 (2003).
39. M. M. Matzuk, M. R. McKeown, P. Filippakopoulos, Q. Li, L. Ma, J. E. Agno, M. E. Lemieux, S. Picaud, R. N. Yu, J. Qi, S. Knapp, J. E. Bradner, Small-molecule inhibition of BRDT for male contraception. Cell 150, 673-684 (2012).